Tokyo Tape
Sign in
← Medinet

Annual report

2370.TEDINET S100PT7B
Period2021-10-01 → 2022-09-30
Filed2022-12-15
StandardJapan GAAP
ConsolidatedNo
Data checks13 of 13 passed
Key figures · 92
MetricValuePeriodScopeSource row
Revenue¥634m2021-10-01 → 2022-09-30StandaloneNet sales
Revenue¥683m2020-10-01 → 2021-09-30StandaloneNet sales
Revenue¥783m2019-10-01 → 2020-09-30dStandaloneNet sales (5-year summary)
Revenue¥1.1bn2018-10-01 → 2019-09-30dStandaloneNet sales (5-year summary)
Revenue¥998m2017-10-01 → 2018-09-30dStandaloneNet sales (5-year summary)
Revenue¥958m2017-10-01 → 2018-09-30dStandaloneNet sales (5-year summary)
Operating income−¥1.3bn2021-10-01 → 2022-09-30StandaloneOperating income
Operating income−¥1.1bn2020-10-01 → 2021-09-30StandaloneOperating income
Ordinary income−¥1.3bn2021-10-01 → 2022-09-30StandaloneOrdinary income
Ordinary income−¥871m2020-10-01 → 2021-09-30StandaloneOrdinary income
Ordinary income−¥837m2019-10-01 → 2020-09-30dStandaloneOrdinary income loss (5-year summary)
Ordinary income−¥995m2018-10-01 → 2019-09-30dStandaloneOrdinary income loss (5-year summary)
Ordinary income−¥2.7bn2017-10-01 → 2018-09-30dStandaloneOrdinary income loss (5-year summary)
Ordinary income−¥2.7bn2017-10-01 → 2018-09-30dStandaloneOrdinary income loss (5-year summary)
Profit before tax−¥1.2bn2021-10-01 → 2022-09-30StandaloneIncome before income taxes
Profit before tax−¥838m2020-10-01 → 2021-09-30StandaloneIncome before income taxes
Net income (owners)−¥3.0bn2017-10-01 → 2018-09-30dStandaloneProfit loss attributable to owners of parent (5-year summary)
Net income−¥1.3bn2021-10-01 → 2022-09-30StandaloneProfit loss
Net income−¥843m2020-10-01 → 2021-09-30StandaloneProfit loss
Net income−¥842m2019-10-01 → 2020-09-30dStandaloneNet income loss (5-year summary)
Net income−¥795m2018-10-01 → 2019-09-30dStandaloneNet income loss (5-year summary)
Net income−¥3.1bn2017-10-01 → 2018-09-30dStandaloneNet income loss (5-year summary)
Total assets¥6.1bnat 2022-09-30StandaloneAssets
Total assets¥5.4bnat 2021-09-30StandaloneAssets
Total assets¥5.2bnat 2020-09-30dStandaloneTotal assets (5-year summary)
Total assets¥3.1bnat 2019-09-30dStandaloneTotal assets (5-year summary)
Total assets¥3.9bnat 2018-09-30dStandaloneTotal assets (5-year summary)
Total assets¥3.9bnat 2018-09-30dStandaloneTotal assets (5-year summary)
Total liabilities¥566mat 2022-09-30StandaloneLiabilities
Total liabilities¥475mat 2021-09-30StandaloneLiabilities
Net assets / equity¥5.5bnat 2022-09-30StandaloneNet assets
Net assets / equity¥4.9bnat 2021-09-30StandaloneNet assets
Net assets / equity¥4.8bnat 2020-09-30dStandaloneNet assets
Net assets / equity¥2.6bnat 2019-09-30dStandaloneNet assets (5-year summary)
Net assets / equity¥3.3bnat 2018-09-30dStandaloneNet assets (5-year summary)
Net assets / equity¥3.3bnat 2018-09-30dStandaloneNet assets (5-year summary)
Cash and deposits¥4.5bnat 2022-09-30StandaloneCash and deposits
Cash and deposits¥4.1bnat 2021-09-30StandaloneCash and deposits
Cash & equivalents¥4.5bnat 2022-09-30StandaloneCash and cash equivalents
Cash & equivalents¥4.1bnat 2021-09-30StandaloneCash and cash equivalents
Cash & equivalents¥3.6bnat 2020-09-30dStandaloneCash and cash equivalents
Cash & equivalents¥1.4bnat 2019-09-30dStandaloneCash and cash equivalents (5-year summary)
Cash & equivalents¥2.2bnat 2018-09-30dStandaloneCash and cash equivalents (5-year summary)
Operating cash flow−¥1.2bn2021-10-01 → 2022-09-30StandaloneNet cash provided by used in operating activities
Operating cash flow−¥975m2020-10-01 → 2021-09-30StandaloneNet cash provided by used in operating activities
Operating cash flow−¥633m2019-10-01 → 2020-09-30dStandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow−¥938m2018-10-01 → 2019-09-30dStandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow−¥2.5bn2017-10-01 → 2018-09-30dStandaloneNet cash provided by used in operating activities (5-year summary)
Investing cash flow−¥20m2021-10-01 → 2022-09-30StandaloneNet cash provided by used in investment activities
Investing cash flow¥344m2020-10-01 → 2021-09-30StandaloneNet cash provided by used in investment activities
Investing cash flow¥86m2019-10-01 → 2020-09-30dStandaloneNet cash provided by used in investing activities (5-year summary)
Investing cash flow¥50m2018-10-01 → 2019-09-30dStandaloneNet cash provided by used in investing activities (5-year summary)
Investing cash flow¥154m2017-10-01 → 2018-09-30dStandaloneNet cash provided by used in investing activities (5-year summary)
Financing cash flow¥1.6bn2021-10-01 → 2022-09-30StandaloneNet cash provided by used in financing activities
Financing cash flow¥1.1bn2020-10-01 → 2021-09-30StandaloneNet cash provided by used in financing activities
Financing cash flow¥2.8bn2019-10-01 → 2020-09-30dStandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow¥90m2018-10-01 → 2019-09-30dStandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow¥1.1bn2017-10-01 → 2018-09-30dStandaloneNet cash provided by used in financing activities (5-year summary)
EPS (basic)¥-6.332021-10-01 → 2022-09-30StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-4.882020-10-01 → 2021-09-30StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-6.192019-10-01 → 2020-09-30dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-6.712018-10-01 → 2019-09-30dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-26.772017-10-01 → 2018-09-30dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-27.472017-10-01 → 2018-09-30dStandaloneBasic earnings loss per share (5-year summary)
Net assets per share¥26.03at 2022-09-30StandaloneNet assets per share (5-year summary)
Net assets per share¥27.31at 2021-09-30StandaloneNet assets per share (5-year summary)
Net assets per share¥29.6at 2020-09-30dStandaloneNet assets per share (5-year summary)
Net assets per share¥21.1at 2019-09-30dStandaloneNet assets per share (5-year summary)
Net assets per share¥27.56at 2018-09-30dStandaloneNet assets per share (5-year summary)
Net assets per share¥27.03at 2018-09-30dStandaloneNet assets per share (5-year summary)
Equity ratio90.7%at 2022-09-30StandaloneEquity to asset ratio (5-year summary)
Equity ratio90.8%at 2021-09-30StandaloneEquity to asset ratio (5-year summary)
Equity ratio90.7%at 2020-09-30dStandaloneEquity to asset ratio (5-year summary)
Equity ratio82.7%at 2019-09-30dStandaloneEquity to asset ratio (5-year summary)
Equity ratio82.8%at 2018-09-30dStandaloneEquity to asset ratio (5-year summary)
Equity ratio82.7%at 2018-09-30dStandaloneEquity to asset ratio (5-year summary)
ROE-24.1%2021-10-01 → 2022-09-30StandaloneRate of return on equity (5-year summary)
ROE-17.5%2020-10-01 → 2021-09-30StandaloneRate of return on equity (5-year summary)
ROE-23.0%2019-10-01 → 2020-09-30dStandaloneRate of return on equity (5-year summary)
ROE-27.7%2018-10-01 → 2019-09-30dStandaloneRate of return on equity (5-year summary)
ROE-70.0%2017-10-01 → 2018-09-30dStandaloneRate of return on equity (5-year summary)
ROE-72.2%2017-10-01 → 2018-09-30dStandaloneRate of return on equity (5-year summary)
Shares issued211,730,423at 2022-09-30StandaloneTotal number of issued shares (5-year summary)
Shares issued178,750,423at 2021-09-30StandaloneTotal number of issued shares (5-year summary)
Shares issued160,830,423at 2020-09-30dStandaloneTotal number of issued shares (5-year summary)
Shares issued120,875,423at 2019-09-30dStandaloneTotal number of issued shares (5-year summary)
Shares issued118,230,423at 2018-09-30dStandaloneTotal number of issued shares (5-year summary)
Employees96at 2022-09-30StandaloneNumber of employees
Employees83at 2021-09-30StandaloneNumber of employees
Employees78at 2020-09-30dStandaloneNumber of employees
Employees76at 2019-09-30dStandaloneNumber of employees
Employees92at 2018-09-30dStandaloneNumber of employees

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 46
SegmentItemPeriodValue
Reconciling Itemsreconcilingcapex2021-10-01 → 2022-09-30¥13m
Reconciling Itemsreconcilingdepreciation2021-10-01 → 2022-09-30¥22m
Reconciling Itemsreconcilingsegment assetsat 2022-09-30¥5.3bn
Reconciling Itemsreconcilingsegment profit2021-10-01 → 2022-09-30−¥518m
Cellular And Tissue Based Product Businessreportable segmentcapex2021-10-01 → 2022-09-30¥4m
Cellular And Tissue Based Product Businessreportable segmentdepreciation2021-10-01 → 2022-09-30¥28m
Cellular And Tissue Based Product Businessreportable segmentemployeesat 2022-09-3019 pure
Cellular And Tissue Based Product Businessreportable segmentrevenue2021-10-01 → 2022-09-30¥221,000
Cellular And Tissue Based Product Businessreportable segmentrevenue external2021-10-01 → 2022-09-30¥221,000
Cellular And Tissue Based Product Businessreportable segmentsegment assetsat 2022-09-30¥147m
Cellular And Tissue Based Product Businessreportable segmentsegment profit2021-10-01 → 2022-09-30−¥582m
Contracted Cell Manufacturing Businessreportable segmentcapex2021-10-01 → 2022-09-30¥60m
Contracted Cell Manufacturing Businessreportable segmentdepreciation2021-10-01 → 2022-09-30¥56m
Contracted Cell Manufacturing Businessreportable segmentemployeesat 2022-09-3065 pure
Contracted Cell Manufacturing Businessreportable segmentrevenue2021-10-01 → 2022-09-30¥633m
Contracted Cell Manufacturing Businessreportable segmentrevenue external2021-10-01 → 2022-09-30¥633m
Contracted Cell Manufacturing Businessreportable segmentsegment assetsat 2022-09-30¥643m
Contracted Cell Manufacturing Businessreportable segmentsegment profit2021-10-01 → 2022-09-30−¥233m
—segment totalcapex2021-10-01 → 2022-09-30¥64m
—segment totaldepreciation2021-10-01 → 2022-09-30¥84m
—segment totalrevenue2021-10-01 → 2022-09-30¥634m
—segment totalrevenue external2021-10-01 → 2022-09-30¥634m
—segment totalsegment assetsat 2022-09-30¥790m
—segment totalsegment profit2021-10-01 → 2022-09-30−¥815m
Reconciling Itemsreconcilingcapex2020-10-01 → 2021-09-30¥8m
Reconciling Itemsreconcilingdepreciation2020-10-01 → 2021-09-30¥23m
Reconciling Itemsreconcilingsegment assetsat 2021-09-30¥4.6bn
Reconciling Itemsreconcilingsegment profit2020-10-01 → 2021-09-30−¥497m
Cellular And Tissue Based Product Businessreportable segmentcapex2020-10-01 → 2021-09-30¥7m
Cellular And Tissue Based Product Businessreportable segmentdepreciation2020-10-01 → 2021-09-30¥34m
Cellular And Tissue Based Product Businessreportable segmentrevenue2020-10-01 → 2021-09-30¥206,000
Cellular And Tissue Based Product Businessreportable segmentrevenue external2020-10-01 → 2021-09-30¥206,000
Cellular And Tissue Based Product Businessreportable segmentsegment assetsat 2021-09-30¥157m
Cellular And Tissue Based Product Businessreportable segmentsegment profit2020-10-01 → 2021-09-30−¥451m
Contracted Cell Manufacturing Businessreportable segmentcapex2020-10-01 → 2021-09-30¥18m
Contracted Cell Manufacturing Businessreportable segmentdepreciation2020-10-01 → 2021-09-30¥58m
Contracted Cell Manufacturing Businessreportable segmentrevenue2020-10-01 → 2021-09-30¥683m
Contracted Cell Manufacturing Businessreportable segmentrevenue external2020-10-01 → 2021-09-30¥683m
Contracted Cell Manufacturing Businessreportable segmentsegment assetsat 2021-09-30¥666m
Contracted Cell Manufacturing Businessreportable segmentsegment profit2020-10-01 → 2021-09-30−¥132m
—segment totalcapex2020-10-01 → 2021-09-30¥25m
—segment totaldepreciation2020-10-01 → 2021-09-30¥92m
—segment totalrevenue2020-10-01 → 2021-09-30¥683m
—segment totalrevenue external2020-10-01 → 2021-09-30¥683m
—segment totalsegment assetsat 2021-09-30¥824m
—segment totalsegment profit2020-10-01 → 2021-09-30−¥583m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 1,053
ItemContextValueUnit
Term of office information about directors and corporate auditorsFilingDateInstant_jpcrp030000-asr_E05351-000ShinodaTakeshiMember
Original text (Japanese)(注)３
Official title or position information about directors and corporate auditorsFilingDateInstant_jpcrp030000-asr_E05351-000YoshinoKoichiroMember
Original text (Japanese)取締役
Name information about directors and corporate auditorsFilingDateInstant_jpcrp030000-asr_E05351-000YoshinoKoichiroMember
Original text (Japanese)吉野　公一郎
Date of birth information about directors and corporate auditorsFilingDateInstant_jpcrp030000-asr_E05351-000YoshinoKoichiroMember1949-03-25
Career summary information about directors and corporate auditors (text)FilingDateInstant_jpcrp030000-asr_E05351-000YoshinoKoichiroMemberText · Plus
Term of office information about directors and corporate auditorsFilingDateInstant_jpcrp030000-asr_E05351-000YoshinoKoichiroMember
Original text (Japanese)(注)３
Official title or position information about directors and corporate auditorsFilingDateInstant_jpcrp030000-asr_E05351-000IchikawaKunihideMember
Original text (Japanese)取締役
Name information about directors and corporate auditorsFilingDateInstant_jpcrp030000-asr_E05351-000IchikawaKunihideMember
Original text (Japanese)市川　邦英
Date of birth information about directors and corporate auditorsFilingDateInstant_jpcrp030000-asr_E05351-000IchikawaKunihideMember1944-07-29
Career summary information about directors and corporate auditors (text)FilingDateInstant_jpcrp030000-asr_E05351-000IchikawaKunihideMemberText · Plus
Term of office information about directors and corporate auditorsFilingDateInstant_jpcrp030000-asr_E05351-000IchikawaKunihideMember
Original text (Japanese)(注)３
Official title or position information about directors and corporate auditorsFilingDateInstant_jpcrp030000-asr_E05351-000TakigamiShinjiMember
Original text (Japanese)常勤監査役
Name information about directors and corporate auditorsFilingDateInstant_jpcrp030000-asr_E05351-000TakigamiShinjiMember
Original text (Japanese)瀧上　眞次
Date of birth information about directors and corporate auditorsFilingDateInstant_jpcrp030000-asr_E05351-000TakigamiShinjiMember1952-09-17
Career summary information about directors and corporate auditors (text)FilingDateInstant_jpcrp030000-asr_E05351-000TakigamiShinjiMemberText · Plus
Term of office information about directors and corporate auditorsFilingDateInstant_jpcrp030000-asr_E05351-000TakigamiShinjiMember
Original text (Japanese)(注)４
Official title or position information about directors and corporate auditorsFilingDateInstant_jpcrp030000-asr_E05351-000KatayamaTakuroMember
Original text (Japanese)監査役
Name information about directors and corporate auditorsFilingDateInstant_jpcrp030000-asr_E05351-000KatayamaTakuroMember
Original text (Japanese)片山　卓朗
Date of birth information about directors and corporate auditorsFilingDateInstant_jpcrp030000-asr_E05351-000KatayamaTakuroMember1950-10-08
Career summary information about directors and corporate auditors (text)FilingDateInstant_jpcrp030000-asr_E05351-000KatayamaTakuroMemberText · Plus
Term of office information about directors and corporate auditorsFilingDateInstant_jpcrp030000-asr_E05351-000KatayamaTakuroMember
Original text (Japanese)(注)４
Official title or position information about directors and corporate auditorsFilingDateInstant_jpcrp030000-asr_E05351-000HasegawaAkihikoMember
Original text (Japanese)監査役
Name information about directors and corporate auditorsFilingDateInstant_jpcrp030000-asr_E05351-000HasegawaAkihikoMember
Original text (Japanese)長谷川　明彦
Date of birth information about directors and corporate auditorsFilingDateInstant_jpcrp030000-asr_E05351-000HasegawaAkihikoMember1951-07-27
Career summary information about directors and corporate auditors (text)FilingDateInstant_jpcrp030000-asr_E05351-000HasegawaAkihikoMemberText · Plus
Term of office information about directors and corporate auditorsFilingDateInstant_jpcrp030000-asr_E05351-000HasegawaAkihikoMember
Original text (Japanese)(注)５
Footnotes directors and corporate auditors (text)FilingDateInstant_Row1MemberText · Plus
Footnotes directors and corporate auditors (text)FilingDateInstant_Row2MemberText · Plus
Footnotes directors and corporate auditors (text)FilingDateInstant_Row3MemberText · Plus
Footnotes directors and corporate auditors (text)FilingDateInstant_Row4MemberText · Plus
Footnotes directors and corporate auditors (text)FilingDateInstant_Row5MemberText · Plus
Footnotes directors and corporate auditors (text)FilingDateInstant_Row6MemberText · Plus
Footnotes directors and corporate auditors (text)FilingDateInstant_Row7MemberText · Plus
Outside directors and outside corporate auditors (text)FilingDateInstantText · Plus
Audits (text)FilingDateInstantText · Plus
Remuneration for directors and other officers (text)FilingDateInstantText · Plus
Shareholdings (text)FilingDateInstantText · Plus
Reason for increase in number of shares shares not listed investment shares held for purposes other than pure investment reporting companyCurrentYearDuration－
Reason for increase in number of shares shares other than those not listed investment shares held for purposes other than pure investment reporting companyCurrentYearDuration
Original text (Japanese)非上場株式の上場
Name of securities details of specified investment equity securities held for purposes other than pure investment reporting companyCurrentYearInstant_Row1MemberTC BioPharm (Holdings) PLC
Purpose of shareholding quantitative effects of shareholding and reason for increase in number of shares details of specified investment shares held for purposes other than pure investment reporting companyCurrentYearInstant_Row1MemberText · Plus
Whether issuer of aforementioned shares holds reporting companys shares details of specified investment shares held for purposes other than pure investment reporting companyCurrentYearInstant_Row1Member
Original text (Japanese)無
Regulations in accordance with which financial statements have been prepared financial informationCurrentYearDurationText · Plus
Note on independent audit financial informationCurrentYearDurationText · Plus
Description of fact that consolidated financial statements have not been prepared financial informationCurrentYearDuration
Original text (Japanese)　当社は子会社がありませんので、連結財務諸表を作成しておりません。
Remarkable efforts to ensure fair presentation of consolidated financial statements etc financial informationCurrentYearDurationText · Plus
Balance sheet (text)CurrentYearDurationText · Plus
Statement of income (text)CurrentYearDurationText · Plus
Detailed schedule of cost of sales (text)CurrentYearDurationText · Plus
Statement of changes in equity (text)CurrentYearDurationText · Plus

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 13 of 13 passed
balance sheet identitynon_consolidated 2021-09-30pass rounding
balance sheet identitynon_consolidated 2022-09-30pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsnon_consolidated 2020-09-30pass
statement vs summary · net assetsnon_consolidated 2021-09-30pass
statement vs summary · net assetsnon_consolidated 2022-09-30pass
statement vs summary · operating cash flownon_consolidated 2020-10-01/2021-09-30pass
statement vs summary · operating cash flownon_consolidated 2021-10-01/2022-09-30pass
statement vs summary · revenuenon_consolidated 2020-10-01/2021-09-30pass
statement vs summary · revenuenon_consolidated 2021-10-01/2022-09-30pass
statement vs summary · total assetsnon_consolidated 2021-09-30pass
statement vs summary · total assetsnon_consolidated 2022-09-30pass